289 results Stibbe advises Cimpress Stibbe advises Cimpress on the sale of Albelli to Gilde Buy Out Partners and the Albelli Management. Stibbe advises KKR Stibbe assisted KKR on the sale of Capsugel to Lonza Group AG. Stibbe advises Blackstone Stibbe has advised Blackstone on its sale of the DoubleTree by Hilton Hotel in Amsterdam to Anbang. Stibbe advises Q-Park Stibbe advises Q-Park on the irrevocable and unconditional offer from KKR Infrastructure to acquire 100% of the outstanding share capital of Q-Park for an enterprise value of €2.95 billion. Stibbe advises Moody’s Corporation Stibbe is advising Moody’s Corporation, the US credit rating agency, on its € 3 billion acquisition of Bureau van Dijk, a global provider of business intelligence and company information, from Swedish private equity firm EQT. Stibbe advises Sealed Air on sale of its Diversey business Stibbe advises Sealed Air Corporation, a NYSE listed company, on the sale of its Diversey Care division and the food hygiene and cleaning business to Bain Capital Private Equity. Stibbe advises Clayton Dubilier & Rice LLC Stibbe advised private equity firm Clayton Dubilier & Rice LLC on the dual-track exit process of Mauser Group N.V., a global producer of industrial packaging. Stibbe advises Tata Communications Stibbe advises Tata Communications on its investment in Teleena Holding B.V., a mobile virtual network enabler headquartered in the Netherlands. Stibbe advises EFG Hermes Stibbe advises EFG Hermes Private Equity on the acquisition by Vortex, its renewable energy platform, of a 365 MW solar energy portfolio in the UK from TerraForm Power with an enterprise value of approximately GBP 470 million. Stibbe advises The Blackstone Group Stibbe advises The Blackstone Group. Stibbe advises NYSE Euronext Stibbe advises NYSE Euronext on the USD 8.2 billion acquisition by IntercontinentalExchange. Stibbe advises Vestar Capital Partners Advising on the sale of one of the world's largest manufacturers of wheelchairs, Sunrise Medical, to Equistone Partners Europe. Stibbe advises Lindsay Goldberg Advising Lindsay Goldberg on the acquisition of Plasticum Group. The acquisition fits well with Lindsay Goldberg's acquisition of Weener Plastic Packaging Group in Germany earlier in 2012. Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital. Stibbe advises Silver Lake Advising private equity investor Silver Lake on the EUR 1 billion acquisition of Global Blue. Stibbe advises UCC Holdings Co Advising the Japanese coffee company UCC Holdings Co. on the acquisition of United Coffee (formerly the Dutch "Three Moles") from CapVest Equity Partners. Stibbe advises leading private equity player Stibbe advised a leading European private equity player on Luxembourg corporate and finance matters related to numerous investments. Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Pagination Previous page Page 14 Current page 15 Page 16 Page 17 Next page
Stibbe advises Cimpress Stibbe advises Cimpress on the sale of Albelli to Gilde Buy Out Partners and the Albelli Management.
Stibbe advises Blackstone Stibbe has advised Blackstone on its sale of the DoubleTree by Hilton Hotel in Amsterdam to Anbang.
Stibbe advises Q-Park Stibbe advises Q-Park on the irrevocable and unconditional offer from KKR Infrastructure to acquire 100% of the outstanding share capital of Q-Park for an enterprise value of €2.95 billion.
Stibbe advises Moody’s Corporation Stibbe is advising Moody’s Corporation, the US credit rating agency, on its € 3 billion acquisition of Bureau van Dijk, a global provider of business intelligence and company information, from Swedish private equity firm EQT.
Stibbe advises Sealed Air on sale of its Diversey business Stibbe advises Sealed Air Corporation, a NYSE listed company, on the sale of its Diversey Care division and the food hygiene and cleaning business to Bain Capital Private Equity.
Stibbe advises Clayton Dubilier & Rice LLC Stibbe advised private equity firm Clayton Dubilier & Rice LLC on the dual-track exit process of Mauser Group N.V., a global producer of industrial packaging.
Stibbe advises Tata Communications Stibbe advises Tata Communications on its investment in Teleena Holding B.V., a mobile virtual network enabler headquartered in the Netherlands.
Stibbe advises EFG Hermes Stibbe advises EFG Hermes Private Equity on the acquisition by Vortex, its renewable energy platform, of a 365 MW solar energy portfolio in the UK from TerraForm Power with an enterprise value of approximately GBP 470 million.
Stibbe advises NYSE Euronext Stibbe advises NYSE Euronext on the USD 8.2 billion acquisition by IntercontinentalExchange.
Stibbe advises Vestar Capital Partners Advising on the sale of one of the world's largest manufacturers of wheelchairs, Sunrise Medical, to Equistone Partners Europe.
Stibbe advises Lindsay Goldberg Advising Lindsay Goldberg on the acquisition of Plasticum Group. The acquisition fits well with Lindsay Goldberg's acquisition of Weener Plastic Packaging Group in Germany earlier in 2012.
Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital.
Stibbe advises Silver Lake Advising private equity investor Silver Lake on the EUR 1 billion acquisition of Global Blue.
Stibbe advises UCC Holdings Co Advising the Japanese coffee company UCC Holdings Co. on the acquisition of United Coffee (formerly the Dutch "Three Moles") from CapVest Equity Partners.
Stibbe advises leading private equity player Stibbe advised a leading European private equity player on Luxembourg corporate and finance matters related to numerous investments.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.